Higgins M R, Grace M, Dossetor J B
Can Med Assoc J. 1977 Oct 22;117(8):880-3.
The results of treatment in 213 patients with end-stage renal disease who underwent hemodialysis, peritoneal dialysis or transplantation, or a combination, between 1962 and 1975 were analysed. Comparison by censored survival analysis showed significantly better (P less than 0.01) patient survival with the integrated therapy of dialysis and transplantation than with either form of dialysis alone. There was no significant difference in survival of males and females but survival at the extremes of age was poorer. Analysis of survival by major cause of renal failure indicated best survival in patients with congenital renal disease. Graft and patient survival rates at 1 year after the first transplantation were 42% and 69%. The major cause of death in this series was vascular disease but infection was responsible for 50% of deaths after transplantation. While integration of dialysis with transplantation produces best patient survival, this course is possible only when sufficient cadaver kidneys are available.
对1962年至1975年间接受血液透析、腹膜透析、移植或联合治疗的213例终末期肾病患者的治疗结果进行了分析。通过截尾生存分析比较发现,透析与移植的综合治疗患者生存率显著高于单独任何一种透析形式(P<0.01)。男性和女性的生存率无显著差异,但年龄两端的生存率较差。按肾衰竭主要病因分析生存率表明,先天性肾病患者生存率最佳。首次移植后1年的移植物和患者生存率分别为42%和69%。该系列中的主要死亡原因是血管疾病,但感染导致移植后50%的死亡。虽然透析与移植相结合可使患者生存率最佳,但只有在有足够的尸体肾时才能采用这种治疗方案。